T1	Participants 119 157	Japanese familial hypercholesterolemia
T2	Participants 630 684	17 heterozygous FH patients (age: 54.1 years; 5 males)
T3	Participants 862 898	Fifteen patients completed the trial
T4	Participants 174 208	familial hypercholesterolemia (FH)
